Stock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data Disappoints [Yahoo! Finance]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Yahoo! Finance
The stock sank after disappointing higher-dose WVE-007 obesity data underperformed the lower dose. Trading volume reached 49.9 million shares, coming in about 1,153% above its three-month average of 4 million shares. Wave Life Sciences IPO'd in 2015 and has fallen 61% since going public. How the markets moved today The S&P 500 fell 1.76% to 6,476, while the Nasdaq Composite lost 2.38% to finish at 21,408. Within biotechnology , industry peers Ionis Pharmaceuticals closed at $74.24 (+2.12%) and Alnylam Pharmaceuticals ended at $328.16 (-0.16%), underscoring stock-specific trial risk for RNA-focused drug developers. What this means for investors Three months after Wave Life Sciences' stock soared from $7 to $21 on positive data from positive WVE-007 weight loss data, its stock plummeted from $12 to $6 in today's session after the company delivered an underwhelming update. While data from patients taking a 240 mg dose showed acceptable fat loss after six months, those taking a la
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- Is This Weight Loss Drug Stock a Buy on the Dip? [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Obesity Data Highlights Visceral Fat Focus Over Weight Loss [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Ltd. (WVE) PT Increased to $52 at Canaccord Following Pipeline Review [Yahoo! Finance]Yahoo! Finance
- Wave Life Sciences Crashes Deep into Oversold Territory as Obesity Drug Data Disappoints. Should You Buy the Dip? [Yahoo! Finance]Yahoo! Finance
- WVE Posts Interim Data From Phase I Study on WVE-007, Stock Tanks [Yahoo! Finance]Yahoo! Finance
WVE
Earnings
- 2/26/26 - Miss
WVE
Sec Filings
- 3/30/26 - Form SCHEDULE
- 3/30/26 - Form 4
- 3/26/26 - Form 4
- WVE's page on the SEC website